000 | 01978 a2200481 4500 | ||
---|---|---|---|
005 | 20250514004946.0 | ||
264 | 0 | _c20010927 | |
008 | 200109s 0 0 eng d | ||
022 | _a0898-6568 | ||
024 | 7 |
_a10.1016/s0898-6568(01)00178-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLee, K | |
245 | 0 | 0 |
_acAMP potentiates H(2)O(2)-induced ERK1/2 phosphorylation without the requirement for MEK1/2 phosphorylation. _h[electronic resource] |
260 |
_bCellular signalling _cSep 2001 |
||
300 |
_a645-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aColforsin _xpharmacology |
650 | 0 | 4 |
_aCyclic AMP _xphysiology |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEstrenes _xpharmacology |
650 | 0 | 4 |
_aFlavonoids _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
650 | 0 | 4 | _aJurkat Cells |
650 | 0 | 4 |
_aLymphocyte Specific Protein Tyrosine Kinase p56(lck) _xmetabolism |
650 | 0 | 4 | _aMAP Kinase Kinase 1 |
650 | 0 | 4 | _aMAP Kinase Kinase 2 |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xmetabolism |
650 | 0 | 4 | _aMitogen-Activated Protein Kinase 3 |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyrrolidinones _xpharmacology |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xphysiology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
700 | 1 | _aEsselman, W J | |
773 | 0 |
_tCellular signalling _gvol. 13 _gno. 9 _gp. 645-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0898-6568(01)00178-4 _zAvailable from publisher's website |
999 |
_c11421090 _d11421090 |